Modification of medical prostheses

• US 7,238,363 B2
• Filed: 03/31/2005
• Issued: 07/03/2007
• Est. Priority Date: 04/02/2004
• Status: Expired due to Fees

• Current Assignee: Baylor College of Medicine (Baylor College)
• Original Assignee: Baylor College of Medicine (Baylor College)
• Inventors: Darouiche, Rabih O., Mansouri, Mohammad D.
• Primary Examiner(s): KENNEDY, SHARON E
• Application Number:
  US11/095,975
• Publication Number:
  US 20050271694A1
• Time in Patent Office: 824 Days
• Field of Search: 424/423, 427/2.1, 427/2.12, 427/2.13, 427/2.24, 427/2.25
• US Class Current: 424/423
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61L 2/0082 using chemical substances
• CPC Class Codes: A61L 2300/104 Silver, e.g. silver sulfadiazine
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/406 Antibiotics
• CPC Class Codes: A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
• CPC Class Codes: A61L 2300/608 having two or more layers
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

The incorporation of one or more therapeutic agents on metallic and non-metallic medical prostheses is provided. The therapeutic agent can be used, for example, to prevent, treat, or reduce bacterial and fungal infections associated with these implants. Additionally, the therapeutic agents can be used to effect other therapeutic benefits. Specifically, a bilayer therapeutic coating is applied in two steps. Additionally, non-antimicrobial therapeutic agents may be incorporated in this coating to treat, prevent, modify, or stimulate certain clinical bioactivities.

Claims

1. A method of coating at least a portion of a medical device with a therapeutic agent comprising the steps of:

forming a first composition by combining at least the following;

a therapeutic agent,

an acidic component,

a matrix component selected from the group consisting of hide powder, collagen, gelatin, cartilage, tendon, ligament, bone, keratin, fibrin, albumin, globulin, hydroxylapatite, and any combination thereof; and

,

glycerol;

applying said first composition to at least a portion of said medical device to form a first layer;

forming a second composition comprising a cyanoacrylate; and

,

applying said second composition on said first layer to form a second layer.

2. The method of claim 1, further comprising the step of drying said first layer.

3. The method of claim 2, wherein said step of drying is performed in the dark.

4. The method of claim 1, further comprising the step of drying said second layer.

5. The method of claim 1, further comprising the steps of drying said first layer and drying said second layer.

6. The method of claim 1, wherein said matrix component is a combination of hide powder and collagen, said hide powder is added to achieve a 5% to 50% (w/v) concentration and said collagen is added to achieve a 0.1% to 20% (w/v) concentration in said first solution.

7. The method of claim 1, wherein said acid solution comprises a short chain monocarboxylic acid having a liquidity state below 90°

C. and a pKa of 3 to 5.

8. The method of claim 1, wherein said acidic component is an acid solvent or acidic solution and said acid solvent or acidic solution is combined with said hide powder or collagen at a temperature range of 25°

C. to 90°

C. and mixed until a clear homogeneous solution is obtained.

9. The method of claim 1, wherein said glycerol is added such that the final concentration of glycerol is between 0.5% and 10%.

10. The method of claim 1, wherein said glycerol in said first composition is added after said therapeutic agent, said acidic component, and said matrix component.

11. The method of claim 1, wherein said step of applying said first composition to at least a portion of said medical device is selected from the group consisting of immersing the medical device in the first composition, spraying the first composition onto the medical device, pouring the first composition over the medical device, blotting the first composition on the medical device, smearing the first composition on the medical device, rolling the medical device in the first composition, brushing the first composition on the medical device, and any combination thereof.

12. The method of claim 1, wherein said cyanoacrylate is selected from the group consisting of methyl cyanoacrylate, ethyl cyanoacrylate, butyl cyanoacrylate, octyl cyanoacrylate, hexyl cyanoacrylate, decyl cyanoacrylate, methoxy ethyl cyanoacrylate, isoamyl cyanoacrylate, isopropyl cyanoacrylate and any combination thereof.

13. The method of claim 1, wherein said step of applying said second composition is selected from the group consisting of immersing the medical device in the second composition, spraying the second composition onto the medical device, pouring the second composition over the medical device, blotting the second composition on the medical device, smearing the second composition on the medical device, rolling the medical device in the second composition, brushing the second composition on the medical device, and any combination thereof.

14. The method of claim 1, further comprising the step of drying said first layer from about 1 hour to about 24 hours.

15. The method of claim 14, wherein said first layer is dried for about 16 hours.

16. The method of claim 1, further comprising the step of drying said second layer from about 5 minutes to about 18 hours.

17. The method of claim 16, wherein said second layer is dried for about 12 hours.

18. The method of claim 1, further comprising the step of applying a cyanoacrylate coat as a primer before said step of applying said first composition.

19. The method of claim 1, further comprising the step of controlling the viscosity of said second composition comprising a cyanoacrylate.

20. The method of claim 1, further comprising the step of controlling the temperature of said second composition comprising a cyanoacrylate.

21. The method of claim 1, further comprising the step of exposing the coating device to moisture after said step of applying said second composition on said first layer.

22. The method of claim 1, wherein said first composition comprises hide powder at a concentration of about 29% (w/v).

23. The method of claim 1, wherein said first composition comprises collagen at a concentration of about 0.5% (w/v).

24. The method of claim 1, wherein said first composition comprises glycerol at a concentration of about 1.25% (w/v).

25. The method of claim 1, wherein said therapeutic agent comprises a combination selected from the group consisting of:

at least one antibiotic and at least one antiseptic;

at least one antibiotic and at least one disinfectant;

at least one antiseptic and at least one disinfectant; and

,

at least one antimicrobial agent.

26. The method of claim 1, wherein said therapeutic agent comprises at least one antimicrobial agent.

27. An implantable medical device comprising:

a body having one or more surfaces;

a first coating on at least a portion of said body, said first coating comprising;

glycerol,

a therapeutic agent,

an acidic component, and;

a matrix component selected from the group consisting of hide powder, collagen, gelatin, cartilage, tendon, ligament, bone, keratin, fibrin, albumin, globulin, hydroxylapatite, and any combination thereof;

a second coating on at least a portion of said first coating, said second coating comprising a cyanoacrylate.

28. The medical device of claim 27, wherein the therapeutic agent is an antimicrobial agent.

29. The medical device of claim 28 wherein said antimicrobial agent is selected from the group consisting of methylisothiazolone, thymol, α

-terpineol, cetylpyridinium chloride, chloroxylenol, hexachlorophene, chlorhexidine and other cationic biguanides, methylene chloride, iodine, iodophores, triclosan, taurinamides, nitrofurantoin, methenamine, aldehydes, azylic acid, heavy metals, benzyl peroxide, alcohols, brilliant green, gentian violet, triacetin, salicylic acid, boric acid, carboxylic acids and their salts, erythromycin, nafcillin, cefazolin, imipenem, astreonam, gentamicin, tobramycin, streptomycin, amikacin, neomycin, sulfamethoxazole, vancomycin, ciprofloxacin, trimethoprim, rifampin, metronidazole, clindamycin, teicoplanin, mupirocin, azithromycin, clarithromycin, ofoxacin, lomefloxacin, norfloxacin, nalidixic acid, sparfloxacin, pefloxacin, amifloxacin, gatifloxacin, moxifloxacin, gemifloxacin, enoxacin, fleroxacin, minocycline, doxcycycline, tetracycline, tigecycline, oritavancin, daptomycin, dalbavancin, linezolid, temafloxacin, tosufloxacin, clinafloxacin, sulbactam, clavulanic acid, amphotericin B, fluconazole, miconazole, ravuconazole, posaconazole, clotrimazole, econazole, tioconazole, oxiconazole, bifonazole, isoconazole, fenticonazole, itraconazole, ketoconazole, voriconazole, terbinafine, caspofungin, anidulafungin, micafungin, nystatin, penicillins, cephalosporins, carbepenems, beta-lactams antibiotics, aminoglycosides, macrolides, lincosamides, glycopeptides, tetracylines, chloramphenicol, quinolones, fucidines, sulfonamides, trimethoprims, rifamycins, oxalines, streptogramins, oxazolidinones, lipepeptides, ketolides, polyenes, azoles, echinocandines, and any combination thereof.

30. The medical device of claim 29 wherein said antimicrobial agent comprises heavy metal.

31. The medical device of claim 30, wherein said heavy metal is silver.

32. The medical device of claim 28 wherein said antimicrobial agent is a combination of two antimicrobial agents and is selected from the group consisting of chlorhexidine and methylisothiazolone;

chlorhexidine and α

-terpineol;

thymol and chloroxylenol;

thymol and methylisothiazolone;

chlorhexidine and cetylpyridinium chloride;

chlorhexidine and chloroxylenol;

chlorhexidine, methylisothiazolone and thymol;

methylisothiazolone and α

-terpineol;

minocycline and rifampin; and

chlorhexidine, methylisothiazolone and α

-terpineol.

33. The medical device of claim 28, wherein said antimicrobial agent is an antibiotic.

34. The medical device of claim 33, wherein said antibiotic is selected from the group consisting of penicillins, cephalosporins, carbepenems, other beta-lactams antibiotics, aminoglycosides, amphenicols, ansamycins, macrolides, lincosamides, glycopeptides, polypeptides, tetracylines, chloramphenicol, quinolones, fucidins, sulfonamides, sulfones, nitrofurans, diaminopyrimidines, trimethoprims, rifamycins, oxalines, streptogramins, lipopeptides, ketolides, polyenes, azoles, echinocandins, and any combination thereof.

35. The medical device of claim 27, wherein the therapeutic agent is an antimicrobial agent comprised of minocycline and rifampin.

36. The medical device of claim 27, wherein said therapeutic agent is selected from the group consisting of analgesics, anti-inflammatories, antidepressants, antiparasitics, anticancer drugs, anesthetics, antiallergics, anticoagulants, antidiabetics, antihypercholesterolemics, antihyperlipidemics, antineoplastics, calcium regulators, antihypertensives, antihypotensives, antihypothyroids, antihyperthyroids, antileukemics, antimanics, antiprotozoals, antivirals, reverse transcriptase inhibitors, antiamebics, antiarthritics, antirheumatics, antihemorrhagics, cardiotonics, contraceptives, antipsychotics, antispasmodics, antithrombotics, vasodilators, digestive aids, diuretics, enzymes, steroids, growth stimulators, immunosuppressants, immunomodulators, peristalitic stimulators, respiratory stimulators, and any combination thereof.

37. The medical device of claim 27, wherein the material comprising said medical device is selected from the group consisting of metals, metal alloys, carbon, carbon fibers, carbon polymer, ceramic, rubber, plastic, nylon, silicone, silicon, germanium, tin, gallium arsenide, polyurethane, polyethylene, polyvinyl chloride, polytetrafluoroethylene tetraphthalate, polyethylene tetraphthalate, polytetrafluoroethylene, polyglycolic acid, expanded polytetrafluoroethylene, latex, elastomers, polymers, polyglycolic acid, polylactide-co-glycolide, and polylactic acid, polymethyl methacrylate, latex, gelatin, collagen, albumin, globulin, and any combination thereof.

38. The medical device of claim 27, wherein the medical device is a catheter selected from the group consisting of peripherally insertable central venous catheters, dialysis catheters, long term tunneled central venous catheters, peripheral venous catheters, short-term central venous catheters, arterial catheters, pulmonary artery Swan-Ganz catheters, urinary catheters, long term non-tunneled central venous catheters, peritoneal catheters, and ventricular catheters.

39. The medical device of claim 27, wherein the medical device is selected from the group consisting of long term urinary devices, tissue bonding urinary devices, penile prostheses, vascular grafts, extravascular grafts, urinary stents, vascular catheter ports, wound drain tubes, drug delivery systems, neurotransmitters, epidural catheters, cerebrospinal fluid draining systems, hydrocephalus shunts, pacemaker systems, implantable stimulators, implantable infusion pumps, ventricular bypass assist devices, tissue expanders, implantable pulse generators, maxillofacial implants, mandibular implants, contraceptive tubal occlusion devices, contraceptive intrauterine devices, artificial anal sphincters, artificial urinary sphincters, vascular dilators, extravascular dilators, intravascular stents, extravascular stents, small joint replacements, temporary joint replacements, urinary dilators, heart valves, orthopedic implants, heart assist devices, mammary implants, dental devices, pacemakers, defibrillators, hip prostheses, knee prostheses, spinal prostheses, shoulder prostheses, joint prostheses, fracture fixation devices, external fixation pins, intramedullary nails, screws, plates, rods, and cages.

40. The medical device of claim 27, wherein said cyanoacrylate is selected from the group consisting of methyl cyanoacrylate, ethyl cyanoacrylate, butyl cyanoacrylate, octyl cyanoacrylate, hexyl cyanoacrylate, decyl cyanoacrylate, methoxy ethyl cyanoacrylate, isoamyl cyanoacrylate, isopropyl cyanoacrylate and any combination thereof.

41. The medical device of claim 27, wherein said therapeutic agent comprises a combination selected from the group consisting of:

at least one antibiotic and at least one antiseptic;

at least one antibiotic and at least one disinfectant;

at least one antiseptic and at least one disinfectant; and

,

at least one antimicrobial agent.